Strategic Wealth Partners’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-187
Closed -$5 424
2019
Q3
$5 Buy
+187
New +$6.57K ﹤0.01% 638

Other funds holding SBIO

Strategic Wealth Partners's SBIO Position: Q4 2019 in Review

Strategic Wealth Partners sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2019, closing a stake of 187 shares — an estimated $5 sold.

Strategic Wealth Partners first reported a position in SBIO in Q3 2019 and held it in 1 quarter. The position peaked at $5 in Q3 2019. 51 funds tracked by Wall St. Rank hold SBIO as of Q4 2019.

  • Strategic Wealth Partners reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2019 after selling out during the quarter.
  • Strategic Wealth Partners sold 187 ALPS Medical Breakthroughs ETF shares in Q4 2019, an estimated $5.
  • Strategic Wealth Partners first reported a position in ALPS Medical Breakthroughs ETF in Q3 2019 and held it in 1 quarter.
  • Strategic Wealth Partners's ALPS Medical Breakthroughs ETF position peaked at $5 in Q3 2019.
  • 51 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2019.

Based on Strategic Wealth Partners's 13F filing for Q4 2019, filed 30 Jan 2020.